NAMBUDRIPAD ALLERGY RESEARCH FOUNDATION (EIN 330750192) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2001

Legal Domicile

Principal Officer

DEVI NAMBUDRIPAD

Phone

7145238900

Tax Period

2023-01-01 to 2023-12-31

NAMBUDRIPAD ALLERGY RESEARCH FOUNDATION, founded in 2001, is a micro nonprofit in the Diseases & Disorders sector that reported $88K in total revenue in fiscal year 2023. Revenue surged 27% from the prior year, signaling strong growth momentum. Expenses of $75K left a modest 14% surplus.

Mission

DEDICATED TO ALLERGY RESEARCH IN COMPLEMENTARY AND ALTERNATIVE MEDICINE. WE BELIEVE THAT RESEARCH AND EDUCATION ARE ESSENTIAL TO THE PROGRESS OF FUTURE INTERGRATIVE MEDICINE. OUR GOAL IS TO IMPROVE HEALTHCARE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $17,670

Program Service Revenue $69,940

Investment Income $0

Other Revenue $0

TOTAL REVENUE $87,610

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $58,733

Other Expenses $75,373

TOTAL EXPENSES $75,373

Year-over-Year Comparison

	2023	2022	Change
Revenue	$87,610	$69,007	+0.3%
Expenses	$75,373	$72,353	+0.0%
Net Income	$12,237	$-3,346	-4.7%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
LIEZL APANTE	DIRECTOR	N/A	Director	$0	$0	$0
KEITH CHRISTIAN	DIRECTOR	N/A	Director	$0	$0	$0
MELISSA CHRISTIAN	DIRECTOR	N/A	Director	$0	$0	$0
RAJSREE NAMBUDRIPAD	ASSISTANT DI	N/A	Director	$0	$0	$0
MARGARET WU	DIRECTOR	N/A	Director	$0	$0	$0
DEVI NAMBUDRIPAD	PRESIDENT	N/A	Officer	$0	$0	$0
KRIS NAMBUDRIPAD	VICE-PRESIDE	N/A	Officer	$0	$0	$0
ROY NAMBUDRIPAD	SECRETARY/TR	N/A	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2023	$87,610	$75,373	$16,941	$12,237
2022	$69,007	$72,353	$20,111	$-3,346
2021	$86,057	$64,650	$24,992	$21,407
2020	$71,026	$74,859	$27,634	$-3,833
2019	$91,337	$131,263	$32,140	$-39,926
2018	$141,677	$172,027	$34,796	$-30,350

NAMBUDRIPAD ALLERGY RESEARCH FOUNDATION